Immunogenicity of Salmonella typhi Ty21a vaccine for young children
- PMID: 1937790
- PMCID: PMC259034
- DOI: 10.1128/iai.59.11.4291-4293.1991
Immunogenicity of Salmonella typhi Ty21a vaccine for young children
Abstract
An attenuated Salmonella typhi Ty21a vaccine was administered to 18 infants and toddlers (less than or equal to 24 months old) to determine its safety and immunogenicity. The vaccination (10(9) CFU per dose, three doses) was well tolerated. However, after the vaccination there was no evidence of a humoral or cellular immune response to S. typhi. The vaccine used was known to be immunogenic for older children and adults. The results support the view that the immunogenicity of Ty21a is age dependent.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources